Search

Author/Creator Moeck, Greg

1. 1055. ARGONAUT-IV: Susceptibility of Carbapenem-resistant Klebsiellae to Ceftibuten/VNRX-5236. (4th December 2021)

Authors:
Mack, Andrew R; Bethel, Christopher; Marshall, Steven; Patel, Robin; Patel, Robin; van Duin, David; Fowler, Vance G; Rhoads, Daniel D; Jacobs, Michael; van den Akker, Focco; Six, David A; Moeck, Greg; Papp-Wallace, Krisztina M; Bonomo, Robert A
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S619
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1055. ARGONAUT-IV: Susceptibility of Carbapenem-resistant Klebsiellae to Ceftibuten/VNRX-5236. (4th December 2021)

Authors:
Mack, Andrew R; Bethel, Christopher; Marshall, Steven; Patel, Robin; Patel, Robin; van Duin, David; Fowler, Vance G; Rhoads, Daniel D; Jacobs, Michael; van den Akker, Focco; Six, David A; Moeck, Greg; Papp-Wallace, Krisztina M; Bonomo, Robert A
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S619
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 1063. ARGONAUT-V: Susceptibility of Multidrug-Resistant (MDR) Pseudomonas aeruginosa to Cefepime-Taniborbactam. (4th December 2021)

Authors:
Mack, Andrew R; Bethel, Christopher; Marshall, Steven; Patel, Robin; Patel, Robin; van Duin, David; Fowler, Vance G; Rhoads, Daniel D; Jacobs, Michael; van den Akker, Focco; Six, David A; Moeck, Greg; Papp-Wallace, Krisztina M; Bonomo, Robert A
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S623
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 1063. ARGONAUT-V: Susceptibility of Multidrug-Resistant (MDR) Pseudomonas aeruginosa to Cefepime-Taniborbactam. (4th December 2021)

Authors:
Mack, Andrew R; Bethel, Christopher; Marshall, Steven; Patel, Robin; Patel, Robin; van Duin, David; Fowler, Vance G; Rhoads, Daniel D; Jacobs, Michael; van den Akker, Focco; Six, David A; Moeck, Greg; Papp-Wallace, Krisztina M; Bonomo, Robert A
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S623
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 1263. Assessment of Cefepime (FEP)-Taniborbactam (TAN) Human Exposures to Suppress the Emergence of Resistance among Serine (SBL)- and Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacteria (GNB) in a Hollow Fiber Infection Model (HFIM). (31st December 2020)

Authors:
Avery, Lindsay M; Vernacchio, Salvador; McLaughlin, Lisa; Xerri, Luigi; Moeck, Greg; Pevear, Daniel
Journal:
Open forum infectious diseases
Issue:
Volume 7:Number 1(2020) Supplement
Page Start:
S648
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 133. ARGONAUT-III: Susceptibility of Carbapenem-resistant Klebsiellae to Cefepime-Taniborbactam. (4th December 2021)

Authors:
Mack, Andrew R; Bethel, Christopher; Marshall, Steven; Patel, Robin; Patel, Robin; van Duin, David; Fowler, Vance G; Rhoads, Daniel D; Jacobs, Michael; van den Akker, Focco; Six, David A; Moeck, Greg; Papp-Wallace, Krisztina M; Bonomo, Robert A
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 590. Activities of Cefepime-Taniborbactam and Ceftazidime-Avibactam against Cefepime-Resistant Respiratory Gram-Negative Pathogens in a Hollow Fiber Infection Model. (15th December 2022)

Authors:
Avery, Lindsay M; Avery, Lindsay M; Edwards, Mitchell; Yi, Fan; Sabato, Philip E; Moeck, Greg; Pevear, Daniel C
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. 731. CERTAIN-1: A Phase 3 Study of Cefepime-Taniborbactam Efficacy and Safety in the Treatment of Complicated Urinary Tract Infections (cUTI), including Acute Pyelonephritis (AP). (15th December 2022)

Authors:
McGovern, Paul C; Wagenlehner, Florian; Gasink, Leanne; Moeck, Greg; McLeroth, Patrick L; Beth, Mary; Dane, Aaron; Henkel, Tim
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗